Clin2
NCT06635226Possibly a fitRecruiting

Safety study of ID110521156 in healthy adults

Healthy Adult Subjects

This study tests a new investigational drug called ID110521156 in healthy adults. The goal is to see if the drug is safe and how the body processes it. It may be for people who are overweight or obese.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
36 people
Ages
19 years to 50 years
Study type
Interventional

Who can take part

  • You must be in good general health with no major medical conditions.
  • You must be between 19 and 50 years old.
  • Your BMI must be 27 or higher, and you must weigh at least 50 kg (about 110 lbs).
  • Women must not be pregnant or breastfeeding, and must be either postmenopausal or surgically sterile.
  • Men who can have children must agree to use effective birth control during the study and for 90 days after the last dose.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07640438Recruiting· Phase 1
Safety Study of New Drug in Healthy Adults

This is a Phase 1 safety study testing a new investigational drug in healthy volunteers with no serious medical conditions. Researchers will give some participants the drug and others a placebo (inactive treatment) to see how safe the drug is and how the body responds to it.

Hangzhou, Zhejiang
NCT07232121Recruiting· Phase 1
Safety study of DF5112 in healthy adults

This study tests a new drug called DF5112 in healthy adults to find the safest dose. It helps doctors learn how the drug works in the body before testing it in people with a condition.

Sydney, New South Wales
NCT07580794Recruiting· Phase 1
Safety Study of New Drug HSK56630 in Healthy People

This is an early-stage safety test of a new investigational drug called HSK56630 in healthy volunteers with no major medical conditions. Researchers will monitor how your body tolerates the drug and what side effects might occur.

Bayswater, Victoria
NCT07518589Not yet recruiting· Phase 1
Testing a new weight-management drug in healthy adults

This early-stage trial tests how safe and tolerable CMS-D008, an experimental weight-management medicine, is in healthy adults who are overweight or obese. Researchers will gradually increase the dose to find the right amount and monitor how your body responds.

NCT07662057Recruiting· Phase 1
Safety study of AB102 in healthy volunteers

This trial tests a new medicine called AB102 in healthy people to see if it is safe and how the body processes it. It may help researchers understand the right dose for future studies.

Groningen
NCT07771777Not yet recruiting· Phase 1
Safety study of an experimental drug in healthy adults

This trial tests a new investigational drug called SYH2056 in healthy volunteers to see if it is safe and how the body handles it. It also checks how food affects the drug. Participating may help determine if the drug can be developed for future patients.

Hear when a new Healthy Adult Subjects trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.